Production (Stage)
Autolus Therapeutics plc
AUTL
$1.54
$0.010.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.16% | 64.23% | -79.05% | -27.92% | -32.35% |
| Total Depreciation and Amortization | 26.08% | 17.01% | 40.54% | 25.33% | -4.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -58.47% | -135.19% | -90.57% | 171.98% | 169.68% |
| Change in Net Operating Assets | -28.69% | -112.55% | 118.66% | -1,434.88% | -2.24% |
| Cash from Operations | -86.52% | -52.76% | -90.95% | -33.91% | 4.49% |
| Capital Expenditure | -1,446.53% | -652.34% | -540.12% | 80.84% | 85.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -11,072.05% | -25,870.82% | -540.12% | 80.84% | 85.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -69.57% | 4,525.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -906.39% | 1,717.80% |
| Cash from Financing | -- | 130,365.22% | 4,525.00% | -849.32% | 81,350.51% |
| Foreign Exchange rate Adjustments | 400.25% | -491.04% | 505.57% | -80.39% | -116.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.34% | -2,502.23% | 5.02% | -48.03% | 1,417.59% |